# Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

> **NCT02762877** · — · TERMINATED · sponsor: **Genomic Health®, Inc.** · enrollment: 140 (actual)

## Conditions studied

- Non Small Cell Lung Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02762877
- **Lead sponsor:** Genomic Health®, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2018-07-01
- **Final completion:** 2019-06-19
- **Target enrollment:** 140 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762877, "Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02762877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*